Sanofi to Merge European API Plants into Separate Major API Company

Sanofi to Merge European API Plants into Separate Major API Company

GALWAY, IRELAND--March 4, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--French pharmaceutical major Sanofi has announced plans to spin off six of its active pharmaceutical ingredients (API) manufacturing sites in Europe into one , large standalone API producer.

Within this article: Details proposed spin-off, estimated sales, impact on global API production, Coronavirus impact on current manufacturing

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)